Trial Information

Summary: Do you take one of these medications for SCHIZOPHRENIA: Zyprexa, Risperdal, Risperdal Consta, Invega, Seroquel or Abilify?

If so, you may want to participate in a medical research study currently being conducted by The Hospital of Central Connecticut. The purpose of the study is to test an investigational medication to improve thinking and memory in those taking one of the drugs listed above.

Patient Inclusion Criteria

  • 18 - 65 years old
  • Have a diagnosis of schizophrenia
  • Be taking one of the schizophrenia medications listed above for at least the past 2 months.

Contact:

Alison Oville, Psychiatry Research Manager
The Hospital of Central Connecticut
Psychiatry & Behavioral Health Research
100 Grand Street
New Britain, CT 06050
Telephone: 860-224-5597
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:45:08 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA